
    
      This is a multi-center study under a common protocol. Approximately 20-30 patients will be
      enrolled across 5 sites in the U.S. The study population is females at least 21 years of age
      who have attempted but have not been satisfied with conservative therapy for their fecal
      incontinence symptoms. The study follow-up is two years.
    
  